Fecal Microbiota Transplant National Registry

Launched by AMERICAN GASTROENTEROLOGICAL ASSOCIATION · Oct 27, 2017

Keywords

ClinConnect Summary

The Fecal Microbiota Transplant National Registry is a clinical trial that aims to gather important information about the safety and effectiveness of fecal microbiota transplantation (FMT) and other similar gut-related treatments. FMT involves taking healthy stool from a donor and placing it into a patient’s gut to help restore the balance of good bacteria. This trial will track patients who receive these treatments to see how well they work both in the short term and over a longer period.

To participate in this trial, individuals must be able to give their consent and will need to receive FMT or a related product within 90 days after agreeing to join. Both patients receiving the treatment and healthy individuals providing stool samples as donors can join, as long as they have internet or phone access. Importantly, people who are currently incarcerated cannot participate. Those who join the study can expect to contribute valuable information that may help improve future treatments for gut health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Recipient Inclusion Criteria
• • Ability to give informed consent
• • Receiving FMT or other gut-related microbiota product within 90 days after providing consent
• • Access to internet and/or telephone
• • Donor Inclusion
• • Ability to give informed consent
• • Providing stool sample for FMT
• Exclusion Criteria:
• • Incarceration